These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33373678)

  • 1. Coffee effectively attenuates impaired attention in ADORA2A C/C-allele carriers during chronic sleep restriction.
    Baur DM; Lange D; Elmenhorst EM; Elmenhorst D; Bauer A; Aeschbach D; Landolt HP
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul; 109():110232. PubMed ID: 33373678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of ADORA2A modulate psychomotor vigilance and the effects of caffeine on neurobehavioural performance and sleep EEG after sleep deprivation.
    Bodenmann S; Hohoff C; Freitag C; Deckert J; Rétey JV; Bachmann V; Landolt HP
    Br J Pharmacol; 2012 Mar; 165(6):1904-1913. PubMed ID: 21950736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated caffeine intake suppresses cerebral grey matter responses to chronic sleep restriction in an A
    Lin YS; Lange D; Baur DM; Foerges A; Chu C; Li C; Elmenhorst EM; Neumaier B; Bauer A; Aeschbach D; Landolt HP; Elmenhorst D
    Sci Rep; 2024 Jun; 14(1):12724. PubMed ID: 38830861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited Efficacy of Caffeine and Recovery Costs During and Following 5 Days of Chronic Sleep Restriction.
    Doty TJ; So CJ; Bergman EM; Trach SK; Ratcliffe RH; Yarnell AM; Capaldi VF; Moon JE; Balkin TJ; Quartana PJ
    Sleep; 2017 Dec; 40(12):. PubMed ID: 29029309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine administration at night during extended wakefulness effectively mitigates performance impairment but not subjective assessments of fatigue and sleepiness.
    Paech GM; Banks S; Pajcin M; Grant C; Johnson K; Kamimori GH; Vedova CB
    Pharmacol Biochem Behav; 2016 Jun; 145():27-32. PubMed ID: 27061779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double-blind, placebo-controlled, crossover study of the effects of repeated-dose caffeine on neurobehavioral performance during 48 h of total sleep deprivation.
    Hansen DA; Ramakrishnan S; Satterfield BC; Wesensten NJ; Layton ME; Reifman J; Van Dongen HPA
    Psychopharmacology (Berl); 2019 Apr; 236(4):1313-1322. PubMed ID: 30539266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Genetic Variations in ADORA2A in the Association between Caffeine Consumption and Sleep.
    Erblang M; Drogou C; Gomez-Merino D; Metlaine A; Boland A; Deleuze JF; Thomas C; Sauvet F; Chennaoui M
    Genes (Basel); 2019 Dec; 10(12):. PubMed ID: 31817803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine, caffeine, and performance: from cognitive neuroscience of sleep to sleep pharmacogenetics.
    Urry E; Landolt HP
    Curr Top Behav Neurosci; 2015; 25():331-66. PubMed ID: 24549722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PER3 and ADORA2A polymorphisms impact neurobehavioral performance during sleep restriction.
    Rupp TL; Wesensten NJ; Newman R; Balkin TJ
    J Sleep Res; 2013 Apr; 22(2):160-5. PubMed ID: 23171222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness.
    Killgore WD; Rupp TL; Grugle NL; Reichardt RM; Lipizzi EL; Balkin TJ
    J Sleep Res; 2008 Sep; 17(3):309-21. PubMed ID: 18522689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of strategic early-morning caffeine gum administration on association between salivary alpha-amylase and neurobehavioural performance during 50 h of sleep deprivation.
    Pajcin M; White JM; Banks S; Dorrian J; Paech GM; Grant CL; Johnson K; Tooley K; Aidman E; Fidock J; Kamimori GH; Della Vedova CB
    Accid Anal Prev; 2019 May; 126():160-172. PubMed ID: 29402402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic determinants of cognitive responses to caffeine drinking identified from a double-blind, randomized, controlled trial.
    Renda G; Committeri G; Zimarino M; Di Nicola M; Tatasciore A; Ruggieri B; Ambrosini E; Viola V; Antonucci I; Stuppia L; De Caterina R
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):798-807. PubMed ID: 25819143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosinergic mechanisms contribute to individual differences in sleep deprivation-induced changes in neurobehavioral function and brain rhythmic activity.
    Rétey JV; Adam M; Gottselig JM; Khatami R; Dürr R; Achermann P; Landolt HP
    J Neurosci; 2006 Oct; 26(41):10472-9. PubMed ID: 17035531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine may disrupt the impact of real-time drowsiness on cognitive performance: a double-blind, placebo-controlled small-sample study.
    Aidman E; Balin M; Johnson K; Jackson S; Paech GM; Pajcin M; Yates C; Mitchelson E; Kamimori GH; Fidock J; Vedova CD; Banks S
    Sci Rep; 2021 Feb; 11(1):4027. PubMed ID: 33597580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption.
    Rogers PJ; Hohoff C; Heatherley SV; Mullings EL; Maxfield PJ; Evershed RP; Deckert J; Nutt DJ
    Neuropsychopharmacology; 2010 Aug; 35(9):1973-83. PubMed ID: 20520601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The
    Rahimi MR; Semenova EA; Larin AK; Kulemin NA; Generozov EV; Łubkowska B; Ahmetov II; Golpasandi H
    Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADOR2A C Allele Carriers Exhibit Ergogenic Responses to Caffeine Supplementation.
    Grgic J; Pickering C; Bishop DJ; Del Coso J; Schoenfeld BJ; Tinsley GM; Pedisic Z
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32168870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of caffeine and caffeine withdrawal on mood and cognitive performance degraded by sleep restriction.
    Rogers PJ; Heatherley SV; Hayward RC; Seers HE; Hill J; Kane M
    Psychopharmacology (Berl); 2005 Jun; 179(4):742-52. PubMed ID: 15887055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of
    Muñoz A; López-Samanes Á; Aguilar-Navarro M; Varillas-Delgado D; Rivilla-García J; Moreno-Pérez V; Del Coso J
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32823594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case-control field study on the relationships among type 2 diabetes, sleepiness and habitual caffeine intake.
    Urry E; Jetter A; Holst SC; Berger W; Spinas GA; Langhans W; Landolt HP
    J Psychopharmacol; 2017 Feb; 31(2):233-242. PubMed ID: 27649774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.